Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxaban.

Gosselin RC, Adcock Funk DM, Taylor JM, Francart SJ, Hawes EM, Friedman KD, Moll S.

Arch Pathol Lab Med. 2014 Dec;138(12):1680-4. doi: 10.5858/arpa.2013-0750-OA.

PMID:
25427046
2.

DNA methylation of a GC repressor element in the smooth muscle myosin heavy chain promoter facilitates binding of the Notch-associated transcription factor, RBPJ/CSL1.

Rozenberg JM, Tesfu DB, Musunuri S, Taylor JM, Mack CP.

Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2624-31. doi: 10.1161/ATVBAHA.114.304634. Epub 2014 Oct 16.

PMID:
25324571
3.

GRAF1 promotes ferlin-dependent myoblast fusion.

Lenhart KC, Becherer AL, Li J, Xiao X, McNally EM, Mack CP, Taylor JM.

Dev Biol. 2014 Sep 15;393(2):298-311. doi: 10.1016/j.ydbio.2014.06.025. Epub 2014 Jul 11.

PMID:
25019370
4.

Nuclear RhoA signaling regulates MRTF-dependent SMC-specific transcription.

Staus DP, Weise-Cross L, Mangum KD, Medlin MD, Mangiante L, Taylor JM, Mack CP.

Am J Physiol Heart Circ Physiol. 2014 Aug 1;307(3):H379-90. doi: 10.1152/ajpheart.01002.2013. Epub 2014 Jun 6.

PMID:
24906914
5.

Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).

Cheng Z, DiMichele LA, Rojas M, Vaziri C, Mack CP, Taylor JM.

J Mol Cell Cardiol. 2014 Feb;67:1-11. doi: 10.1016/j.yjmcc.2013.12.002. Epub 2013 Dec 14.

6.

The smooth muscle-selective RhoGAP GRAF3 is a critical regulator of vascular tone and hypertension.

Bai X, Lenhart KC, Bird KE, Suen AA, Rojas M, Kakoki M, Li F, Smithies O, Mack CP, Taylor JM.

Nat Commun. 2013;4:2910. doi: 10.1038/ncomms3910.

7.

The CASZ1/Egfl7 transcriptional pathway is required for RhoA expression in vascular endothelial cells.

Charpentier MS, Taylor JM, Conlon FL.

Small GTPases. 2013 Oct-Dec;4(4):231-5. doi: 10.4161/sgtp.26849. Epub 2013 Oct 22. Review.

8.

Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels.

Hawes EM, Deal AM, Funk-Adcock D, Gosselin R, Jeanneret C, Cook AM, Taylor JM, Whinna HC, Winkler AM, Moll S.

J Thromb Haemost. 2013 Aug;11(8):1493-502. doi: 10.1111/jth.12308.

PMID:
23718677
9.

CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7/RhoA-mediated pathway.

Charpentier MS, Christine KS, Amin NM, Dorr KM, Kushner EJ, Bautch VL, Taylor JM, Conlon FL.

Dev Cell. 2013 Apr 29;25(2):132-43. doi: 10.1016/j.devcel.2013.03.003.

10.

ROCKs cause SHP-wrecks and broken hearts.

Tandon P, Conlon FL, Taylor JM.

Small GTPases. 2012 Oct-Dec;3(4):209-12. doi: 10.4161/sgtp.20960. Epub 2012 Aug 3.

11.

Germline deletion of FAK-related non-kinase delays post-natal cardiomyocyte mitotic arrest.

O'Neill TJ 4th, Mack CP, Taylor JM.

J Mol Cell Cardiol. 2012 Aug;53(2):156-64. doi: 10.1016/j.yjmcc.2012.04.007. Epub 2012 Apr 25.

12.

Quantifying sphingosine-1-phosphate-dependent activation of the RhoGTPases.

Medlin MD, Taylor JM, Mack CP.

Methods Mol Biol. 2012;874:89-97. doi: 10.1007/978-1-61779-800-9_8.

PMID:
22528442
13.

Targeted focal adhesion kinase activation in cardiomyocytes protects the heart from ischemia/reperfusion injury.

Cheng Z, DiMichele LA, Hakim ZS, Rojas M, Mack CP, Taylor JM.

Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):924-33. doi: 10.1161/ATVBAHA.112.245134. Epub 2012 Mar 1.

14.

SHP-2 acts via ROCK to regulate the cardiac actin cytoskeleton.

Langdon Y, Tandon P, Paden E, Duddy J, Taylor JM, Conlon FL.

Development. 2012 Mar;139(5):948-57. doi: 10.1242/dev.067579. Epub 2012 Jan 25.

15.

Quantification of myocyte chemotaxis: a role for FAK in regulating directional motility.

Zajac B, Hakim ZS, Cameron MV, Smithies O, Taylor JM.

Methods Mol Biol. 2012;843:111-23. doi: 10.1007/978-1-61779-523-7_11.

PMID:
22222526
16.

Focal adhesion kinase regulates smooth muscle cell recruitment to the developing vasculature.

Cheng Z, Sundberg-Smith LJ, Mangiante LE, Sayers RL, Hakim ZS, Musunuri S, Maguire CT, Majesky MW, Zhou Z, Mack CP, Taylor JM.

Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2193-202. doi: 10.1161/ATVBAHA.111.232231. Epub 2011 Jul 14.

17.

Enhancement of mDia2 activity by Rho-kinase-dependent phosphorylation of the diaphanous autoregulatory domain.

Staus DP, Taylor JM, Mack CP.

Biochem J. 2011 Oct 1;439(1):57-65. doi: 10.1042/BJ20101700.

18.

Stochastic functional data analysis: a diffusion model-based approach.

Zhu B, Song PX, Taylor JM.

Biometrics. 2011 Dec;67(4):1295-304. doi: 10.1111/j.1541-0420.2011.01591.x. Epub 2011 Mar 18.

19.

Formin homology domain-containing protein 1 regulates smooth muscle cell phenotype.

Staus DP, Blaker AL, Medlin MD, Taylor JM, Mack CP.

Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):360-7. doi: 10.1161/ATVBAHA.110.212993. Epub 2010 Nov 24.

20.

Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation.

Medlin MD, Staus DP, Dubash AD, Taylor JM, Mack CP.

Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1779-86. doi: 10.1161/ATVBAHA.110.209395. Epub 2010 Aug 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk